Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sigurd Liestøl"'
Publikováno v:
Journal of Thrombosis and Haemostasis. 5:2204-2210
To cite this article: Liestol S, Sandset PM, Mowinckel M-C, Wisloff F. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. J Thromb Haemost 2007;
Publikováno v:
Thrombosis Research, 119(Suppl. 1). Elsevier Science
Thrombosis and Haemostasis, 97(6), 938-943. Georg Thieme Verlag
Thrombosis and Haemostasis, 97(6), 938-943. Georg Thieme Verlag
SummaryRecent studies have shown that hormone therapy (HT) is associated with an acquired resistance to activated protein C (APC). The aims of the present study were to evaluate a possible dose-response relationship and differential effects of differ
Autor:
Sigurd Liestøl, Marie-Christine Mowinckel, Per Morten Sandset, Ole Rasmus Ødegaard, Ulrich Abildgaard, Lien My Diep, Mette Lie Larsen, Marianne S. Andresen
Publikováno v:
Thrombosis Research. 113:411-417
Three global assays, the Calibrated Automated Thrombogram (CAT), the ProC Global (PCG), and the Coagulation Inhibitor Potential (CIP) were performed in frozen plasma samples from 24 normal controls and 24 patients with inherited thrombophilia. Six pa
Publikováno v:
Thrombosis Research. 105:177-182
The lupus ratio (LR) test is a normalized ratio of the clotting times obtained with low and high phospholipid (PL) concentrations, where the test plasma is mixed 1:1 with normal pooled plasma (NP). As an integrated, automated, and computer-assisted a
Autor:
Marius Lund-Iversen, Jon Lømo, Thomas Pedersen Bærland, Nils Eide, Sigurd Liestøl, Ellen Sauesund
Publikováno v:
Acta Ophthalmologica. 93
Autor:
Anette L, Eilertsen, Sigurd, Liestøl, Marie-Christine, Mowinckel, H C, Hemker, Per-Morten, Sandset
Publikováno v:
Thrombosis and haemostasis. 97(6)
Recent studies have shown that hormone therapy (HT) is associated with an acquired resistance to activated protein C (APC). The aims of the present study were to evaluate a possible dose-response relationship and differential effects of different HT
Autor:
Sigurd Liestøl, Finn Wisløff, Per Morten Sandset, Eva Marie Jacobsen, Marie-Christine Mowinckel
Publikováno v:
British journal of haematology. 136(1)
Inhibition of tissue factor pathway inhibitor type 1 (TFPI) is one of the mechanisms by which lupus anticoagulants (LA) may upregulate tissue factor (TF) activity. We wanted to examine whether purified immunoglobulin G (IgG) from patients with LA may
Autor:
Sigurd Liestøl, Finn Wisløff
Publikováno v:
Thrombosis research. 115(6)
Introduction Treatment with unfractionated heparin (UH) is known to affect screening tests for lupus anticoagulant (LA). False positive test results are common because confirmatory steps lack sufficient specificity to distinguish between LA and the p
Publikováno v:
Thrombosis research. 108(5-6)
Much has happened since Conley and Hartmann [1] described the lupus inhibitor in two SLE patients in 1952. These patients had prolonged coagulation tests and biologically false positive syphilis tests. Although the term ‘‘lupus anticoagulant’
Publikováno v:
Thrombosis research. 105(2)
The lupus ratio (LR) test is a normalized ratio of the clotting times obtained with low and high phospholipid (PL) concentrations, where the test plasma is mixed 1:1 with normal pooled plasma (NP). As an integrated, automated, and computer-assisted a